Optellum

Optellum was founded in 2016 in the UK. It has raised $1.3M of funding and has 25 employees as of Q2 2020.

 

The company's solution is based on AI & ML technologies applied to the very large clinical dataset. It develops the AI-based Clinical Decision Support software for lung cancer diagnosis & treatment. It identifies at-risk patients, and expedites optimal therapy for patients with cancer, while reducing unnecessary interventions for millions who don't need treatment.